in

India’s Drug Regulator Urges Pharma Lobby to Boost Domestic Manufacturing

India’s Drugs Controller General on Thursday suggested pharma body OPPI—the Organisation of Pharmaceutical Producers of India—change its name to OPII—the Organisation of Pharmaceutical Importers of India, given the lack of domestic manufacturing by its members.

“On the lighter side, looks…

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

FPIs End 3-Day Buying Streak, Record Third Highest Single-Day Selling So Far In 2024

Piyush Goyal Says No Problems Expected for India From Incoming Trump Administration